-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U+VdD8cF6Y85oqddZZV6WJDtkVMxwWxYOJza5eBTvKCz1ZOfGGM5MQ4SnrTgvQgH PPqihhAHRoyqVy8CTEpckQ== 0001193805-10-001917.txt : 20100713 0001193805-10-001917.hdr.sgml : 20100713 20100713172847 ACCESSION NUMBER: 0001193805-10-001917 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100713 DATE AS OF CHANGE: 20100713 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Flynn James E CENTRAL INDEX KEY: 0001352546 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 780 THIRD AVENUE STREET 2: 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-43074 FILM NUMBER: 10950843 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 SC 13G 1 e607271_sc13g-htp.htm Unassociated Document
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 13G
(Rule 13d-102)


INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)

(Amendment No. ____) *


HI-TECH PHARMACAL CO., INC.

(Name of Issuer)


Common Stock

(Title of Class of Securities)


42840B101

(CUSIP Number)


July 2, 2010

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 
o
Rule 13d-1(b)

 
x
Rule 13d-1(c)

 
o
Rule 13d-1(d)

(Page 1 of 13 Pages)

----------
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 

 
 
CUSIP No.   42840B101
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Deerfield Capital, L.P.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a) o
  (b) x
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
289,739
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
289,739
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
289,739
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
 
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
2.34%
12.
TYPE OF REPORTING PERSON*
 
PN
 
 
Page 2 of 13

 
 
CUSIP No.   42840B101
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Deerfield Partners, L.P.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a) o
  (b) x
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
47,278
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
47,278
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
47,278
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
 
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
0.38%
12.
TYPE OF REPORTING PERSON*
 
PN
 
 
Page 3 of 13

 
 
CUSIP No.   42840B101
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Deerfield Management Company, L.P.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a) o
  (b) x
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
458,012
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
458,012
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
458,012
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
 
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
3.70%
12.
TYPE OF REPORTING PERSON*
 
PN
 
 
Page 4 of 13

 

CUSIP No.   42840B101
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Deerfield International Limited
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a) o
  (b) x
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
British Virgin Islands


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
62,418
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
62,418
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
62,418
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
 
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
0.50%
12.
TYPE OF REPORTING PERSON*
 
CO
 
 
Page 5 of 13

 
 
CUSIP No.   42840B101
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Deerfield Special Situations Fund, L.P.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a) o
  (b) x
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
242,461
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
242,461
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
242,461
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
 
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
1.96%
12.
TYPE OF REPORTING PERSON*
 
PN
 
 
Page 6 of 13

 
     
CUSIP No.   42840B101
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Deerfield Special Situations Fund International Limited
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a) o
  (b) x
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
British Virgin Islands


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
395,594
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
395,594
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
395,594
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
 
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
3.20%
12.
TYPE OF REPORTING PERSON*
 
CO
 
 
Page 7 of 13

 
     
CUSIP No.   42840B101
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

James E. Flynn
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a) o
  (b) x
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States


NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
747,751
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
747,751
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
747,751
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
 
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
6.04%
12.
TYPE OF REPORTING PERSON*
 
IN
 
 
Page 8 of 13

 
 
CUSIP No.   42840B101
 
     
Item 1(a).   Name of Issuer:
     
   
HI-TECH PHARMACAL CO., INC.
     
Item 1(b).   Address of Issuer's Principal Executive Offices:
     
   
369 Bayview Avenue
Amityville, New York 11701
     
Item 2(a).   Name of Person Filing:
     
   
James E. Flynn, Deerfield Capital, L.P., Deerfield Partners, L.P.,
Deerfield Management Company, L.P., Deerfield International Limited,
Deerfield Special Situations Fund, L.P., Deerfield Special Situations Fund
International Limited
     
Item 2(b).   Address of Principal Business Office, or if None, Residence:
     
   
James E. Flynn, Deerfield Capital, L.P., Deerfield Partners, L.P.,
Deerfield Management Company, L.P., Deerfield Special Situations Fund, L.P.,
780 Third Avenue, 37th Floor, New York, NY 10017, Deerfield International Limited,
Deerfield Special Situations Fund International Limited, c/o Citi Hedge Fund
Services (B.V.I.) Ltd., Bison Court, Columbus Centre, P.O. Box 3460, Road Town,
Tortola, D8, British Virgin Islands
     
Item 2(c).   Citizenship:
     
   
Mr. Flynn - United States citizen
Deerfield Capital, L.P., Deerfield Partners, L.P., Deerfield Management Company,
L.P. and Deerfield Special Situations Fund, L.P.- Delaware limited partnerships
Deerfield International Limited and Deerfield Special Situations Fund International
Limited - British Virgin Islands corporations
     
Item 2(d).   Title of Class of Securities:
     
   
Common Stock
     
Item 2(e).   CUSIP Number:
     
   
42840B101
     
Item 3.  
If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

(a)    o Broker or dealer registered under Section 15 of the Exchange Act.
       
(b)    o Bank as defined in Section 3(a)(6) of the Exchange Act. 
       
(c)    o Insurance company as defined in Section 3(a)(19) of the Exchange Act.
       
(d)    o Investment company registered under Section 8 of the Investment Company Act.
       
(e)    o An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       
(f)    o An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
       
(g)    o A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
 
 
Page 9 of 13

 
 
(h)    o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
       
(i)    o A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
       
(j)    o Group, in accordance with Rule 13d-1(b)(1)(ii)(J). 
 
Item 4.      Ownership. 
 
     Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
(a)     Amount beneficially owned:
       
     
Deerfield Capital, L.P. – 289,739 shares
Deerfield Partners, L.P. – 47,278 shares
Deerfield Management Company, L.P. – 458,012 shares
Deerfield International Limited - 62,418 shares
Deerfield Special Situations Fund, L.P. – 242,461 shares
Deerfield Special Situations Fund International Limited – 395,594 shares
James E. Flynn – 747,751 shares
       
(b)     Percent of class:
       
     
Deerfield Capital, L.P. – 2.34%
Deerfield Partners, L.P. – 0.38%
Deerfield Management Company, L.P. – 3.70%
Deerfield International Limited – 0.50%
Deerfield Special Situations Fund, L.P. – 1.96%
Deerfield Special Situations Fund International Limited – 3.20%
James E. Flynn – 6.04%
 
(c)     Number of shares as to which such person has:  
           
      (i) Sole power to vote or to direct the vote
All Reporting Persons - 0
           
      (ii) Shared power to vote or to direct the vote   
Deerfield Capital, L.P. – 289,739
Deerfield Partners, L.P. – 47,278
Deerfield Management Company, L.P. – 458,012
Deerfield International Limited – 62,418
Deerfield Special Situations Fund, L.P. – 242,461
Deerfield Special Situations Fund International Limited – 395,594
James E. Flynn - 747,751
 
 
Page 10 of 13

 
 
           
      (iii) Sole power to dispose or to direct the disposition of
All Reporting Persons - 0
           
      (iv) Shared power to dispose or to direct the disposition of   
Deerfield Capital, L.P. – 289,739
Deerfield Partners, L.P. – 47,278
Deerfield Management Company, L.P. – 458.012
Deerfield International Limited – 62,418
Deerfield Special Situations Fund, L.P. – 242,461
Deerfield Special Situations Fund International Limited – 395,594
James E. Flynn - 747,751
 
Item 5.
Ownership of Five Percent or Less of a Class.
 
     If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following o.

 
 
 
Item 6.
Ownership of More Than Five Percent on Behalf of Another Person.
 
     If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
 
N/A
 
 
 
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
 
     If a parent holding company or control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.

N/A
 
 
 
 
 
Page 11 of 13

 

Item 8.
Identification  and  Classification  of Members of the Group.
 
     If a group has filed this schedule pursuant to ss.240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to ss.240.13d-1(c) or ss.240.13d-1(d), attach an exhibit stating the identity of each member of the group.

See Exhibit B
 
 
 
 
Item 9.
Notice of Dissolution of Group.

     Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. (See Item 5.)

N/A
 
 
 
 
Item 10.
Certifications.
 
         "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect."
 
 
Page 12 of 13

 
 
SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
DEERFIELD CAPITAL, L.P.
     
By:
J.E. Flynn Capital LLC, General Partner
 
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
     
     
DEERFIELD PARTNERS, L.P.
     
By:
Deerfield Capital, L.P., General Partner
 
     
By:
J.E. Flynn Capital LLC, General Partner
 
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
     
     
DEERFIELD MANAGEMENT COMPANY, L.P.
     
By:
Flynn Management LLC, General Partner
 
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
     
     
DEERFIELD INTERNATIONAL LIMITED
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
 
 
DEERFIELD SPECIAL SITUATIONS FUND, L.P.
     
By:
Deerfield Capital, L.P., General Partner
 
     
By:
J.E. Flynn Capital LLC, General Partner
 
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
 
DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
 
JAMES E. FLYNN
     
/s/ Darren Levine
 
Darren Levine, Attorney-In-Fact
 

 
Date:  July 13, 2010
 
 
Page 13 of 13

 
 
Exhibit List

Exhibit A.     Joint Filing Agreement.

Exhibit B.      Item 8 Statement.

Exhibit C.      Power of Attorney.
 
 
 

 
 
Exhibit A

Agreement

         The undersigned agree that this Schedule 13G, and all amendments thereto, relating to the Common Stock of Hi-Tech Pharmacal Co., Inc. shall be filed on behalf of the undersigned.

 
DEERFIELD CAPITAL, L.P.
     
By:
J.E. Flynn Capital LLC, General Partner
 
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
     
     
DEERFIELD PARTNERS, L.P.
     
By:
Deerfield Capital, L.P., General Partner
 
     
By:
J.E. Flynn Capital LLC, General Partner
 
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
     
     
DEERFIELD MANAGEMENT COMPANY, L.P.
     
By:
Flynn Management LLC, General Partner
 
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
     
     
DEERFIELD INTERNATIONAL LIMITED
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
 
 
DEERFIELD SPECIAL SITUATIONS FUND, L.P.
     
By:
Deerfield Capital, L.P., General Partner
 
     
By:
J.E. Flynn Capital LLC, General Partner
 
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
 
DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED
     
By:
/s/ Darren Levine
 
 
Darren Levine, Attorney-In-Fact
 
 
JAMES E. FLYNN
     
/s/ Darren Levine
 
Darren Levine, Attorney-In-Fact
 
 
 
 

 
 
Exhibit B


Due to the relationships between them, the reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.
 
 
 

 
 
Exhibit C
 
POWER OF ATTORNEY

Know all by these presents, each of the undersigned hereby constitutes and appoints Darren Levine, signing singly, the undersigned’s true and lawful attorney-in-fact to:
 
(1)           execute for and on behalf of the undersigned (i) Forms 3,  4 and 5 (and all amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules thereunder and (ii) reports on Schedule 13G and Schedule 13D (and all amendments thereto)  in accordance with Section 13 of the Exchange Act and the rules thereunder, in each case with respect to the beneficial ownership of securities by the undersigned;
 
(2)           do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 or Schedule 13G or Schedule 13D, complete and execute any amendment or amendments thereto, and file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
 
(3)           take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
 
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Section 13 or Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
 
 
 

 
 
IN WITNESS WHEREOF, each the undersigned has caused this Power of Attorney to be executed as of this 13th day of July, 2010.
 
 
DEERFIELD CAPITAL, L.P.
     
By:
J.E. Flynn Capital LLC, General Partner
 
     
By:
/s/ James E. Flynn
 
 
James E. Flynn, President
 
 
 
DEERFIELD SPECIAL SITUATIONS FUND, L.P.
     
By:
Deerfield Capital, L.P., General Partner
 
     
By:
J.E. Flynn Capital LLC, General Partner
 
     
By:
/s/ James E. Flynn
 
 
James E. Flynn, President
 
 
DEERFIELD MANAGEMENT COMPANY, L.P.
     
By:
Flynn Management LLC, General Partner
 
     
By:
/s/ James E. Flynn
 
 
James E. Flynn, President
 
 
 
DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED
     
By:
/s/ James E. Flynn
 
 
James E. Flynn, Director
 
 
DEERFIELD PARTNERS, L.P.
     
By:
Deerfield Capital, L.P., General Partner
 
     
By:
J.E. Flynn Capital LLC, General Partner
 
     
By:
/s/ James E. Flynn
 
 
James E. Flynn, President
 
 
 
DEERFIELD INTERNATIONAL LIMITED
     
By:
/s/ James E. Flynn
 
 
James E. Flynn, Director
 
 
 
JAMES E. FLYNN
     
/s/ James E. Flynn
 

 
-----END PRIVACY-ENHANCED MESSAGE-----